CARMAT Launches €10 Million Global Offering

CARMAT has announced a €10 million global offering to strengthen its financial position and expand its operations. The offering includes €7 million in subscription commitments and consists of two parts: a reserved offering for qualified investors and a public offering for retail investors via PrimaryBid.

The issue price for the new shares is set at 0.77 euro each. The PrimaryBid Offer closes on January 30, 2025, while the Reserved Offering closes on January 31, 2025, subject to early closure.

Following this offering, CARMAT will extend its cash runway to mid-May 2025. Despite this, there is still an estimated residual financing need of €30 to 35 million over the next 12 months.

CEO Stéphane Piat highlights the increasing adoption of the Aeson® artificial heart across Europe. The company aims to double its sales in 2025, supported by anticipated scientific publications and increasing Aeson® adoption.